Structures by: Guan J. N.
Total: 7
2-(4-<i>tert</i>-Butylphenyl)-5-{3,4-dibutoxy-5-[5-(4-<i>tert</i>-butylphenyl)- 1,3,4-oxadiazol-2-yl]-2-thienyl}-1,3,4-oxadiazole
C36H44N4O4S
Acta Crystallographica Section E (2008) 64, 11 o2154
a=19.421(4)Å b=17.387(4)Å c=10.424(2)Å
α=90.00° β=94.24(3)° γ=90.00°
5-(4-methylphenyl)-1,3,4-thiadiazol-2-amine
C9H9N3S
Acta Crystallographica Section E (2009) 65, 5 o976
a=12.284(3)Å b=7.3730(15)Å c=11.263(2)Å
α=90.00° β=109.09(3)° γ=90.00°
3-[4-(Trifluoromethyl)phenyl]propanoic acid
C10H9F3O2
Acta Crystallographica Section E (2009) 65, 4 o844
a=7.9028(19)Å b=8.288(2)Å c=9.238(3)Å
α=63.381(15)° β=85.20(3)° γ=65.70(2)°
Ethyl 2-(2-hydroxy-5-nitrophenyl)acetate
C10H11NO5
Acta Crystallographica Section E (2011) 67, 2 o509
a=11.066(2)Å b=10.860(2)Å c=8.6970(17)Å
α=90.00° β=97.85(3)° γ=90.00°
Ethyl 5-methylimidazo[1,2-<i>a</i>]pyridine-2-carboxylate
C11H12N2O2
Acta Crystallographica Section E (2010) 66, 8 o1999
a=17.164(3)Å b=10.521(2)Å c=13.759(3)Å
α=90.00° β=124.77(3)° γ=90.00°
5-(2-Methoxyphenyl)-1,3,4-thiadiazol-2-yl 2-methoxybenzoate hemihydrate
C17H14N2O4S,0.5(H2O)
Acta Crystallographica Section E (2011) 67, 5 o1046
a=29.858(6)Å b=14.542(3)Å c=7.6710(15)Å
α=90.000° β=95.19(3)° γ=90.00°
6-[4-(Diphenylamino)phenyl]quinoline 1-oxide
C27H20N2O
Acta Crystallographica Section E (2012) 68, 8 o2543
a=16.774(3)Å b=9.6130(19)Å c=13.253(3)Å
α=90.00° β=107.05(3)° γ=90.00°